Home › Pharmacology › Lipid Transport and Lipoproteins

Lipid Transport and Lipoproteins

Q: What is the function of the NPC1L1 protein in lipid metabolism?

The NPC1L1 (Niemann-Pick C1-Like 1) protein is located in the enterocytes of the small intestine and functions as a transport system ensuring the absorption of dietary cholesterol.

Transportus lipidorum et lipoproteina

For medical students2 min readUpdated 2026-10-10

The transport of hydrophobic lipid molecules in the aqueous environment of blood plasma is carried out by lipoproteins, which are spherical supramolecular complexes. The body utilizes exogenous (intestinal) and endogenous (hepatic) transport pathways regulated by specific enzymes and membrane receptors.

Cholesterol synthesisHMG-CoA reductase is the rate-limiting enzyme for cholesterol synthesis from acetyl-CoA.

Intestinal absorptionThe *NPC1L1* transporter mediates cholesterol uptake by small intestinal enterocytes.

TG hydrolysisCapillary lipoprotein lipase hydrolyzes triglycerides within chylomicrons and VLDL.

Hepatic regulationDepletion of intracellular cholesterol stores increases hepatocyte receptor density for uptake.

Lipoprotein Structure and the Role of Apolipoproteins

Highly lipophilic compounds—cholesterol (Chol), triglycerides (TGs), and phospholipids (PLs)—are insoluble in blood plasma and cannot travel freely through the vascular system. Lipoproteins are formed to transport them.

All classes of lipoprotein particles share a fundamentally similar structure but differ in their physicochemical properties. These differences are determined by surface proteins known as apolipoproteins (Apo).

Functions of apolipoproteins:

Serve as recognition elements (markers) for target cells;
Ensure selective interaction of particles with receptors and enzymes.

Exogenous Pathway of Dietary Lipid Transport

The exogenous pathway is responsible for delivering dietary lipids from the small intestine to body tissues:

Absorption in enterocytes: Cholesterol enters intestinal cells via a specialized transport system, the NPC1L1 (Niemann-Pick C1-Like 1) protein.
Formation and secretion: Chylomicrons are formed in the intestine and secreted into the blood plasma.
Vascular phase: The enzyme lipoprotein lipase is located on the endothelial cells of capillaries (particularly in adipose tissue). It hydrolyzes chylomicron triglycerides, releasing fatty acids and glycerol to meet tissue energy demands.
Clearance: The remaining particles, known as chylomicron remnants, are taken up by the liver and degraded in hepatocyte lysosomes.

Endogenous Pathway: Synthesis and Metabolism of VLDL and LDL

The endogenous pathway distributes lipids synthesized within the body:

Cholesterol synthesis: Occurs in the liver from acetyl-CoA. The key regulatory enzyme is HMG-CoA reductase (3-hydroxy-3-methylglutaryl-coenzyme A reductase).
VLDL secretion: The liver releases very-low-density lipoproteins (VLDL) into the bloodstream.
Metabolic cascade: Driven by endothelial lipoprotein lipase, VLDL particles lose fatty acids and glycerol, transforming into remnants—intermediate-density lipoproteins (IDL)—and subsequently into low-density lipoproteins (LDL).
Tissue uptake: LDL particles bind to receptors in peripheral tissues (e.g., adipocytes) or return to the liver via receptor-mediated endocytosis.

Hepatic Receptor Regulation and Cholesterol Excretion

Blood plasma clearance of lipoproteins is controlled by hepatocytes via feedback mechanisms:

Receptor dynamics: Lipoprotein receptors are located on the membranes of liver cells. When intracellular cholesterol is deficient, the density of these receptors increases, enhancing the extraction of cholesterol-rich lipoproteins from the blood.
Elimination: Cholesterol delivered to the liver is converted into bile acids. Cholesterol and bile acids are then secreted via the bile duct into the intestine, where a portion undergoes enterohepatic circulation.

Mnemonic

Sequence of the endogenous particle-shrinking cascade: Liver -> VLDL -> IDL -> LDL -> Receptor uptake.

Frequently asked questions

Which specific apolipoprotein class serves as a marker for chylomicrons?

Apolipoprotein B-48 (ApoB-48) is the marker protein for chylomicrons. Nascent chylomicrons synthesized in the small intestinal mucosa contain only this class of apolipoprotein. In the bloodstream, they acquire ApoC-II and ApoE from high-density lipoproteins, but ApoB-48 remains the specific marker for these particles.

Which group of pharmacological agents inhibits the HMG-CoA reductase enzyme?

HMG-CoA reductase is inhibited by statins (HMG-CoA reductase inhibitors), which block the rate-limiting enzyme of hepatic cholesterol synthesis.

Major representatives of this pharmacological group include:

Simvastatin
Atorvastatin
Rosuvastatin

Cholesterol synthesis inhibition occurs directly inside hepatocytes.

Which drug selectively blocks the NPC1L1 transport system in the intestine?

Ezetimibe selectively blocks the intestinal NPC1L1 transport system. It inhibits cholesterol absorption without affecting the uptake of other steroids.

Its molecular mechanism of action includes:

Inry uptake inhibition — blocking the specific NPC1L1 (Niemann-Pick C1-Like 1) transporter responsible for moving cholesterol from the intestinal lumen into enterocytes.
Upregulation of efflux — stimulating ATP-binding cassette transporters that pump sterols back into the intestinal lumen.

Which lipoproteins perform reverse cholesterol transport from peripheral tissues to the liver?

High-density lipoproteins (HDLs) perform reverse cholesterol transport from peripheral tissues to the liver. They extract excess free cholesterol from peripheral cell membranes and deliver it to hepatocytes for disposal.

This process is a primary anti-atherogenic vascular protection factor. HDLs do not contain apolipoprotein B-100, meaning they are not taken up by peripheral tissues; instead, they scavenge excess lipids, preventing atherosclerosis.

What is the function of the NPC1L1 protein in lipid metabolism?

The NPC1L1 (Niemann-Pick C1-Like 1) protein is located in the enterocytes of the small intestine and functions as a transport system ensuring the absorption of dietary cholesterol.

How does the liver regulate cholesterol uptake from blood plasma?

Via feedback regulation: when internal cholesterol stores are depleted, hepatocytes upregulate lipoprotein receptor density on their membranes, activating the endocytosis of LDL and other particles from the blood.

What happens to chylomicron and VLDL triglycerides within capillaries?

Capillary endothelial lipoprotein lipase hydrolyzes triglycerides into fatty acids and glycerol, which are subsequently taken up by tissues.

Go deeper

Pharmacological inhibition of HMG-CoA reductase and NPC1L1
Molecular mechanism of LDL receptor-mediated endocytosis
The role of lipoprotein lipase in adipocyte metabolism
Enterohepatic circulation of bile acids
Comparative profile of apolipoprotein markers